SpaceX
SPCX
$154.72
+1.89%
Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and operates reusable rocket systems for government and commercial launch customers, and operates the Starlink satellite broadband constellation; in early 2026 it acquired xAI, adding the Grok large language model, the Colossus data center, and the X social network to its portfolio. The company is the dominant Western launch provider and the largest satellite broadband operator, giving it a vertically integrated platform spanning space transportation, connectivity, and artificial intelligence. The current investor narrative centers on the xAI acquisition and the resulting AI-infrastructure ambitions, which have driven a dramatic re-rating since the June 2026 listing, while debate focuses on steep valuation, heavy capital expenditures, widening losses, and upcoming share lockup expirations. Recent headlines highlight both the growth story — the stock is up sharply since its last earnings report — and caution over cash burn and the Fed's first rate hike in three years, which shifts the market's focus toward profitability and self-funding.…
SPCX
SpaceX
$154.72
Related headlines
Investment Opinion: Should I buy SPCX Today?
The synthesized recommendation is Hold, with a speculative bias. The core thesis is that SpaceX possesses a unique, vertically integrated platform in launch, satellite broadband, and AI, but its current valuation (PS 25.2x, EV/Sales 174.5x) already prices in extraordinary execution that is far from guaranteed. The analyst consensus is 'buy' with an average target of $222.42 (+45.6% upside), but the wide target range ($140-$450) and estimated EPS range ($0.30-$7.76) signal low conviction and high uncertainty.
Supporting evidence for a Hold includes: 15.4% YoY revenue growth to $4.694 billion in Q1 2026; a healthy gross margin of 49.1%; a strong cash position of $16.608 billion; and the implied +45.6% upside to the average analyst target. However, these positives are offset by a net loss of $4.276 billion (net margin -91.1%), negative free cash flow of -$9.06 billion, and a forward PE of 87.6x versus an industry average of ~20x. The PS ratio of 25.2x is over 1,100% above the industry average of ~2x, and the EV/Sales of 174.5x is extreme even for high-growth tech.
The biggest risks that could invalidate the thesis are: (1) failure to monetize AI and achieve profitability, leading to further cash burn; (2) lockup expirations causing significant share dilution and selling pressure; and (3) a sustained high-rate environment compressing growth stock multiples. The rating would upgrade to Buy if the company demonstrates a credible path to positive free cash flow and AI revenue materializes, or if the stock pulls back to a more reasonable valuation (e.g., PS below 15x). It would downgrade to Sell if revenue growth decelerates below 10% or if cash reserves drop below $10 billion without a clear path to profitability. Relative to its history (limited) and peers, the stock appears overvalued, and investors are paying a steep premium for future success.
Sign up to view all
SPCX 12-Month Price Forecast
The forward-looking view is neutral with medium confidence. The company's strong revenue growth, healthy gross margin, and dominant market position are offset by extreme valuation, massive losses, and negative free cash flow. The analyst consensus is bullish, but the wide target range and low earnings visibility suggest high uncertainty. The Fed's rate hike adds a macro headwind for unprofitable growth stocks. I would upgrade to bullish if the company demonstrates a credible path to positive free cash flow and AI monetization, or if the stock pulls back to a more reasonable valuation (e.g., PS below 15x). I would downgrade to bearish if revenue growth decelerates below 10% or if cash reserves drop below $10 billion without a clear path to profitability.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on SpaceX's 12-month outlook, with a consensus price target around $222.42 and implied upside of +43.8% versus the current price.
Average Target
$222.42
0 analysts
Implied Upside
+43.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$140 - $450
Analyst target range
There are 19 analysts covering SPCX, with a consensus recommendation of "buy" (mean rating of 1.67, where 1 is Strong Buy and 5 is Strong Sell). The average target price is $222.42, which implies approximately +45.6% upside from the current price of $152.71. The consensus leans bullish, but the wide range of targets suggests significant disagreement about the company's future.
The target range spans from a low of $140 to a high of $450. The low target of $140 implies roughly -8.3% downside and likely assumes margin compression, integration challenges from the xAI acquisition, and continued cash burn. The high target of $450 implies +194.7% upside and likely assumes successful AI monetization, Starlink profitability, and multiple expansion. The wide spread (over 3x between low and high) signals high uncertainty and low conviction. Institutional ratings are sparse, with only one recent action from Oppenheimer maintaining an Outperform rating on June 18, 2026. The estimated EPS average of $4.24 for the forward year, with a range of $0.30 to $7.76, further highlights the lack of earnings visibility. Given the recent IPO and limited coverage history, price discovery may be less efficient, and the stock could remain volatile.
Bulls vs Bears: SPCX Investment Factors
The bear case currently has stronger evidence due to the extreme valuation (PS 25.2x vs. industry ~2x), massive and widening losses (-$4.276 billion in Q1 2026), and deeply negative free cash flow (-$9.06 billion), all against a backdrop of a Fed rate hike that penalizes unprofitable growth. The bull case rests on the analyst consensus buy rating and $222.42 average target (+45.6% upside), 15.4% revenue growth, 49.1% gross margin, and the transformative potential of the xAI acquisition. The single most important tension is whether the AI and Starlink investments can generate sufficient profitability to justify the premium valuation before cash reserves are depleted or lockup expirations trigger a sell-off. If the company demonstrates a credible path to positive free cash flow and AI monetization, the bull case could prevail; otherwise, the stock risks a significant de-rating.
Bullish
- Analyst consensus sees 45.6% upside: 19 analysts cover SPCX with a consensus recommendation of 'buy' (mean rating 1.67) and an average target price of $222.42, implying +45.6% upside from the current $152.71. The high target of $450 implies +194.7% upside, reflecting substantial institutional conviction in the AI and Starlink growth narrative.
- Revenue growth with 49.1% gross margin: Q1 2026 revenue rose 15.4% YoY to $4.694 billion from $4.067 billion, while gross margin remained healthy at 49.1% (gross profit of $2.306 billion). This demonstrates pricing power and a scalable core business even as the company invests heavily in AI infrastructure.
- Massive cash position funds capex: The company held $16.608 billion in cash at the end of Q1 2026 and has demonstrated access to capital markets, issuing $8.43 billion in common stock during the quarter. This liquidity provides a cushion to fund the $10.107 billion in quarterly capex without immediate solvency risk.
- Dominant launch and satellite broadband platform: SpaceX is the dominant Western launch provider and the largest satellite broadband operator, with a vertically integrated platform spanning reusable rockets, Starlink connectivity, and now AI (Grok, Colossus, X). This unique combination creates multiple long-term revenue streams and high barriers to entry.
Bearish
- Extreme valuation leaves no margin for error: SPCX trades at a PS ratio of 25.22x and EV/Sales of 174.49x, versus an Aerospace & Defense industry average PS of roughly 2x — a premium of over 1,100%. The forward PE of 87.6x is 338% above the industry average of ~20x, pricing in extraordinary future success that may not materialize.
- Widening losses and negative free cash flow: Q1 2026 net loss ballooned to $4.276 billion (net margin -91.1%) from $528 million a year earlier, driven by the xAI acquisition. Free cash flow was deeply negative at -$9.06 billion, with operating cash flow of only $1.047 billion against $10.107 billion in capex, forcing reliance on external financing.
- Upcoming share lockup expirations: The company listed on June 12, 2026, and upcoming lockup expirations will release a significant number of shares for sale. Recent news highlights these unlocks as a key risk, potentially pressuring the stock as early investors and employees monetize holdings.
- Fed rate hike shifts focus to profitability: The Fed's first rate hike in three years shifts the AI investment thesis from growth-at-any-cost to profitability and self-funding, favoring cash-rich AI leaders over capital-hungry challengers. With negative FCF and a 0.55 debt-to-equity ratio, SPCX is vulnerable to higher discount rates and tighter capital access.
SPCX Technical Analysis
SPCX is in a powerful but highly volatile uptrend, with a 1-year price change of +519.02% and a 6-month change of +597.45%, though the stock only began trading on June 12, 2026, so the price history is short. At the current price of $152.71, the stock sits at approximately 39.6% of its 52-week range (low $104.83, high $225.64), meaning it is trading in the lower-middle portion of its range after a sharp post-listing spike and subsequent pullback. This positioning suggests the stock is neither at momentum-driven highs nor at deep-value lows, but rather in a consolidation phase following extreme early volatility.
Short-term momentum is mixed: the 1-month change is +9.35%, showing a recent bounce, while the 3-month change is -17.45%, reflecting the significant drawdown from the post-listing peak. This divergence — positive 1-month versus negative 3-month — signals a potential mean-reversion rally within a broader corrective phase, and the relative strength versus SPY is +10.31 over 1 month but -19.45 over 3 months, confirming recent outperformance after a period of underperformance. The max drawdown of -46.35% from the high underscores the stock's extreme volatility, and with a short ratio of 1.55, short-selling pressure appears moderate.
Key technical support lies near the 52-week low of $104.83, which also aligns with the August 2026 lows around $108, while resistance is at the 52-week high of $225.64, with intermediate resistance around $160-$170 from the July consolidation zone. A breakout above $170 would signal renewed bullish momentum and a potential retest of the highs, while a breakdown below $105 would confirm a bearish trend reversal and likely trigger further selling. The stock's beta is not provided, but the 46.35% max drawdown and 597% six-month gain imply volatility far exceeding the broader market, necessitating careful position sizing and risk management.
Beta
—
—
Max Drawdown
-46.4%
Largest decline past year
52-Week Range
$105-$226
Price range past year
Annual Return
+522.6%
Cumulative gain past year
| Period | SPCX Return | S&P 500 |
|---|---|---|
| 1m | +13.0% | +1.0% |
| 3m | +0.1% | +5.5% |
| 6m | +607.9% | +19.9% |
| 1y | +522.6% | +16.0% |
| ytd | +609.4% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SPCX Fundamental Analysis
Revenue is growing rapidly, with Q1 2026 revenue of $4.694 billion representing 15.4% year-over-year growth from $4.067 billion in Q1 2025, but the company swung to a much larger net loss of $4.276 billion from $528 million a year earlier, driven largely by the xAI acquisition and related costs. The revenue growth is solid but not explosive, and the massive increase in net loss suggests that the acquired AI business is currently a significant drag on profitability. The multi-quarter trend shows revenue increasing but profitability deteriorating sharply, which raises questions about the near-term earnings trajectory and the integration of xAI.
Profitability is negative: Q1 2026 net income was -$4.276 billion, with a net margin of -91.1%, compared to -$528 million and -13.0% in Q1 2025. Gross margin remains healthy at 49.1% (gross profit of $2.306 billion), but operating income was -$1.943 billion due to soaring operating expenses of $4.249 billion, including $3.514 billion in R&D and $746 million in SG&A. The operating margin of -41.4% reflects the heavy investment in AI and rocket development, and while the gross margin is typical for a high-tech aerospace company, the bottom-line losses are widening dramatically.
On the balance sheet, the company has a current ratio of 1.45 and a debt-to-equity ratio of 0.55, indicating moderate leverage and adequate short-term liquidity. However, free cash flow is deeply negative at -$9.06 billion in Q1 2026, with operating cash flow of only $1.047 billion against capital expenditures of $10.107 billion, and cash at the end of the period was $16.608 billion. The company relies on external financing, having issued $8.43 billion in common stock and repurchased $4.346 billion, while net cash from financing was $7.125 billion. The negative FCF and high capex suggest significant cash burn, and ROE is -11.95%, reflecting the losses. The cash position provides some cushion, but continued heavy investment in AI and space infrastructure will require ongoing access to capital.
Quarterly Revenue
$4.7B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
49.1%
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SPCX Overvalued?
Because net income is negative (Q1 2026 net income of -$4.276 billion), the PE ratio is not meaningful; the trailing PE is -95.24 and the forward PE is 87.61, based on estimated EPS of $4.24. The forward PE of 87.6x is extremely high, implying the market expects a dramatic profitability turnaround, and the gap between the negative trailing PE and positive forward PE reflects expectations of a swing to profitability. However, the PS ratio of 25.22x and EV/Sales of 174.49x are more relevant for a high-growth, unprofitable company, and both are exceptionally elevated.
Compared to the Aerospace & Defense industry, where typical PS ratios are in the 1-3x range and PE ratios in the 15-25x range, SPCX trades at a massive premium: PS of 25.2x versus an industry average of roughly 2x, a premium of over 1,100%, and forward PE of 87.6x versus an industry average of about 20x, a 338% premium. This premium is justified only if the company can deliver on its AI and Starlink growth narratives, but the current valuation already prices in extraordinary future success. The PEG ratio of 0.0035 is distorted by the negative earnings and is not useful.
Historical valuation data is not available because the company only went public in June 2026, so there is no multi-year PE or PS band to reference. However, the current PS of 25.2x and EV/Sales of 174.5x are at the extreme high end of any reasonable range, suggesting the market is pricing in optimistic expectations. Given the lack of historical context, investors should focus on the forward estimates and the company's ability to execute on its growth and profitability targets.
PE
-95.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
246.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are severe. The company swung to a Q1 2026 net loss of $4.276 billion from $528 million a year earlier, with a net margin of -91.1%, driven by the xAI acquisition and soaring operating expenses of $4.249 billion (including $3.514 billion in R&D). Free cash flow is deeply negative at -$9.06 billion, with operating cash flow of only $1.047 billion against $10.107 billion in capex, forcing reliance on external financing ($8.43 billion in common stock issued). While the current ratio of 1.45 and debt-to-equity of 0.55 suggest moderate leverage, the cash burn rate is unsustainable without continued capital market access, and ROE is -11.95%. Revenue concentration in launch services and Starlink, plus integration risk from xAI, adds operational uncertainty.
Market and competitive risks are elevated. The stock trades at a PS of 25.22x and EV/Sales of 174.49x, versus an industry average PS of roughly 2x, leaving it highly vulnerable to valuation compression if growth slows or profitability disappoints. The Fed's first rate hike in three years shifts investor focus to profitability and self-funding, which could disproportionately hurt capital-hungry challengers like SPCX. Competitive threats include Rocket Lab's diversified revenue and upcoming Iridium acquisition, as well as Anthropic's potential IPO, which could divert AI investment dollars. The stock's beta is not provided, but a max drawdown of -46.35% and a 597% six-month gain imply volatility far exceeding the broader market, making it sensitive to sector rotation and macro shifts.
The worst-case scenario involves a chain of events: continued massive losses, failure to monetize AI, and lockup expirations triggering a sell-off, compounded by further Fed rate hikes. This could drive the stock toward its 52-week low of $104.83 or the analyst low target of $140. From the current price of $152.71, a decline to $104.83 represents a -31.4% loss, while a drop to $140 is -8.3%. Given the max drawdown of -46.35% from the high, a more severe scenario could see the stock fall below $100, implying a loss exceeding 35% from current levels. Investors should brace for extreme volatility and potential capital impairment.
FAQ
The key risks are: (1) Financial: massive net loss of $4.276 billion in Q1 2026 and negative free cash flow of -$9.06 billion, requiring ongoing external financing; (2) Valuation: extreme PS of 25.2x and EV/Sales of 174.5x, vulnerable to compression if growth slows; (3) Market: Fed rate hikes and sector rotation away from unprofitable growth stocks; (4) Company-specific: lockup expirations could trigger insider selling, and integration of xAI may not yield expected synergies. These risks are ranked from most to least severe, with the financial and valuation risks being the most immediate threats to the stock price.
The 12-month forecast has three scenarios: bull case (25% probability) targeting $300-$450, assuming successful AI monetization and profitability; base case (50% probability) targeting $180-$250, assuming steady growth but continued losses; and bear case (25% probability) targeting $104.83-$140, assuming failure to monetize AI and a cash crunch. The base case is most likely, with the average analyst target of $222.42 serving as a key reference. The key assumption is that revenue continues to grow at 15-20% YoY while losses gradually narrow, but free cash flow remains negative.
SPCX appears significantly overvalued on traditional metrics. Its PS ratio of 25.22x is over 1,100% above the Aerospace & Defense industry average of roughly 2x, and its forward PE of 87.6x is 338% above the industry average of ~20x. The EV/Sales of 174.49x is extreme even for high-growth tech. While the company has strong revenue growth (15.4% YoY) and a 49.1% gross margin, the valuation prices in extraordinary future success that is not yet reflected in financials. The market is paying a steep premium for the AI and Starlink narratives, leaving little margin for error.
SPCX is a high-risk, high-reward speculative buy for aggressive investors. The analyst consensus is 'buy' with an average target of $222.42, implying +45.6% upside, but the stock trades at a PS of 25.2x and EV/Sales of 174.5x, far above industry averages. The company is unprofitable with a net margin of -91.1% and negative free cash flow of -$9.06 billion, and upcoming lockup expirations could pressure the stock. It may be a good buy for those with a long-term horizon and tolerance for volatility, but only with careful position sizing and a willingness to endure potential drawdowns of 30% or more.
SPCX is more suitable for long-term investment (minimum 3-5 years) for investors who believe in the AI and Starlink growth stories, given the company's early growth stage, high volatility (max drawdown -46.35%), and no dividend. Short-term trading is extremely risky due to the stock's 597% six-month gain and -17.45% three-month decline, which indicate wild swings. The lack of earnings visibility (estimated EPS range $0.30-$7.76) makes short-term predictions unreliable. A long-term horizon allows time for investments to mature and potential profitability to materialize, but investors must be prepared for significant interim volatility.